Source: http://collections.infocollections.org/whocountry/fr/d/Jh4325e/
Timestamp: 2013-05-23 08:13:34
Document Index: 253172177

Matched Legal Cases: ['ART) 3', 'ART 3', 'ART 3', 'ART 4', 'ART 5', 'ART 5', 'ART 5', 'ART 6', 'ART 7', 'ART 7', 'ART 7', 'ART 10']

Uganda National Antiretroviral Treatment and Care Guidelines for Adults and Children
Uganda National Antiretroviral Treatment and Care Guidelines for Adults and Children (WHO; 2003; 66 pages) Abbreviations Foreword Acknowledgements 1.0 Introduction 2.0 Diagnosing HIV infection and disease 2.1 Voluntary counseling and testing (VCT) 2.2 Laboratory diagnosis and assessment of HIV infection 2.3 Clinical evaluation 2.4 Diagnosing HIV infection in infants and children 3.0 Antiretroviral therapy (ART) 3.1 Goals of ART 3.2 Principles of ART 3.3 Limitations of ART 4.0 Available agents for ART 5.0 When to start ART 5.1 Institutional requirements for starting ART 5.2 In adults and adolescents 5.3 In children and infants 6.0 Recommended regimens of ART 6.1 Recommended starting (first line) regimens in adults and adolescents 6.2 Recommended second line of ART regimens in adults and adolescents 6.3 Recommended first line ART regimens for infants and children 6.4 Recommended second line ART regimens for infants and children 6.5 Recommendations for special groups 7.0 Follow-up and monitoring patients on ART 7.1 Clinical guidelines for monitoring ART 7.2 Laboratory guidelines for monitoring ART 7.3 Monitoring of ART in infants and children 7.4 Follow-up at hospital level 7.5 Follow-up at lower level facilities 7.6 Follow-up in a private clinic setting 7.7 Follow-up at community level 7.8 ART data collection and management 8.0. When to change therapy 8.1 Reasons for changing regimens 8.2 In adults and adolescents 8.3 In infants and older children 9.0 When to stop therapy 9.1 What happens to viral load and CD4+ T-lymphocyte levels during treatment interruptions? 9.2. The risks 9.3. SIT - A strategy for the future? 9.4. Practical tips for treatment interruptions 10.0 Challenges of ART 10.1 Immune reconstitution syndrome 10.2 Patient adherence 10.3 ART in the adolescents 10.4 ART in children 10.5 Sustainable ARV drug supplies and delivery systems 11.0 ART and primary or secondary prophylaxis 12.0 Post-exposure prophylaxis 12.1 Prevention of occupational exposure in health facilities 12.2 Procedure to be followed in the event of injury with a sharp object 12.3 Antiretroviral drugs to be used in post-exposure prophylaxis 12.4 Post-sexual exposure prophylaxis 13.0 Preventing mother to child transmission (PMTCT) 14.0 General HIV care Appendix 1 WHO Staging System for HIV Infection and Disease in Adults Appendix 2 Proposed WHO Staging System for HIV Infection and Disease in Children Appendix 3 ART-associated adverse clinical events Appendix 4 Antiretroviral dosage regimens for adults and adolescents Appendix 5 Antiretroviral dosage regimens for Children and Infants Appendix 6 Antiretroviral Drug Toxicity Appendix 7 Karnofsky (Performance) Score Uganda National Antiretroviral Treatment and Care Guidelines for Adults and Children
Elly T Katabira, FRCP
Moses R Kamya, M.Med
1st Edition - November 2003
Copyright © 2003, Ministry of Health, Republic of Uganda
Any part of these Guidelines may be reproduced in any form without prior permission of the Ministry of Health for non-commercial purposes and due acknowledgement is given.
Printed by Earnest PublishersPlot 17B Nasser Road, P.O. Box 11730, KampalaTel: 232043, 077 - 401018 E-mail: kmernest@lycos.com
Every effort has been made to ensure that drug dosages and treatment schedules are correct and in accordance with current medical practice.
However, medical knowledge is constantly and rapidly changing, particularly in relation to HIV/AIDS. Thus, when using an unfamiliar drug, clinicians are urged to confirm that information (especially with regards to drug usage) complies with the latest standards of practice.
Hence these guidelines will need regular updating based on new knowledge, experiences and practices. We would welcome feedback and comments from the users and experts addressed to:
The Director General Health ServicesAttn: Programme Manager,STD/AIDS Control ProgrammeMinistry of HealthP.O. Box 7272Kampala, UgandaTel: + 256 41 340874Fax: +256 41 231584Email: std-acp@utlonline.co.ug